A Breakthrough in Pain Management: Inside the Promise of Journavx
Risk & Insurance - Apr 03, 2025
Enlyte’s Nikki Wilson offers a fresh take on a promising alternative to opioids, a first-of-its-kind FDA-approved non-addictive medication for pain. The post A Breakthrough in Pain Management: Inside the Promise of Journavx appeared first on Risk & Insurance. ...
Recommended Articles
Posted: Apr 01, 2026
Construction costs for a single data center location can exceed $20 billion — double once technology...
Posted: Apr 01, 2026
The American Society of Safety Professionals identified five themes reshaping workplace safety, incl...
Posted: Apr 01, 2026
A new Munich Re report finds that ransomware, supply chain attacks and AI-driven threats are expandi...